201 related articles for article (PubMed ID: 10168358)
1. The potential systemic effect of topically applied beta-blockers in glaucoma therapy.
Taniguchi T; Kitazawa Y
Curr Opin Ophthalmol; 1997 Apr; 8(2):55-8. PubMed ID: 10168358
[TBL] [Abstract][Full Text] [Related]
2. Topical ophthalmic beta blockers: a comparative review.
Zimmerman TJ
J Ocul Pharmacol; 1993; 9(4):373-84. PubMed ID: 7906296
[TBL] [Abstract][Full Text] [Related]
3. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
Frishman WH; Fuksbrumer MS; Tannenbaum M
J Clin Pharmacol; 1994 Aug; 34(8):795-803. PubMed ID: 7962666
[TBL] [Abstract][Full Text] [Related]
4. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
Brooks AM; Gillies WE
Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.
Frishman WH; Kowalski M; Nagnur S; Warshafsky S; Sica D
Heart Dis; 2001; 3(6):386-97. PubMed ID: 11975823
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.
Cimolai N
Clin Med Res; 2019 Dec; 17(3-4):90-96. PubMed ID: 31462538
[TBL] [Abstract][Full Text] [Related]
7. Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension.
Henness S; Swainston Harrison T; Keating GM
Drugs Aging; 2007; 24(6):509-28. PubMed ID: 17571916
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
Netland PA; Weiss HS; Stewart WC; Cohen JS; Nussbaum LL
Am J Ophthalmol; 1997 Apr; 123(4):465-77. PubMed ID: 9124243
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the ocular beta-blockers.
Sorensen SJ; Abel SR
Ann Pharmacother; 1996 Jan; 30(1):43-54. PubMed ID: 8773166
[TBL] [Abstract][Full Text] [Related]
10. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].
Nygaard HA; Høvding G
Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677
[TBL] [Abstract][Full Text] [Related]
11. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
Diggory P; Cassels-Brown A; Fernandez C
Age Ageing; 1996 Nov; 25(6):424-8. PubMed ID: 9003876
[TBL] [Abstract][Full Text] [Related]
12. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
Schuman JS
Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
[TBL] [Abstract][Full Text] [Related]
13. Systemic drug interactions with topical glaucoma medications.
Gerber SL; Cantor LB; Brater DC
Surv Ophthalmol; 1990; 35(3):205-18. PubMed ID: 1980380
[TBL] [Abstract][Full Text] [Related]
14. [Mode of action, clinical profile and significance of beta-blockers in antiglaucoma therapy].
Schlote T
Klin Monbl Augenheilkd; 2013 Feb; 230(2):120-6. PubMed ID: 23430677
[TBL] [Abstract][Full Text] [Related]
15. Topical ophthalmic medications: what potential for systemic side effects and interactions with other medications?
Goldberg I; Moloney G; McCluskey P
Med J Aust; 2008 Oct; 189(7):356-7. PubMed ID: 18837675
[TBL] [Abstract][Full Text] [Related]
16. Current concepts of pharmacotherapy in hypertension--ophthalmically administered beta blockers and their cardiopulmonary effects.
Sica DA
J Clin Hypertens (Greenwich); 2001; 3(3):175-8. PubMed ID: 11416704
[TBL] [Abstract][Full Text] [Related]
17. The safety of topical beta-blockers in glaucoma treatment.
Goldberg I
Med J Aust; 1996 Apr; 164(8):498-9. PubMed ID: 8614346
[TBL] [Abstract][Full Text] [Related]
18. [Topical optical beta-adrenergic antagonists and quinidine--a risky combination].
Pianka P; Lazar M; Geyer O
Harefuah; 1998 Mar; 134(5):402-3. PubMed ID: 10909562
[No Abstract] [Full Text] [Related]
19. Topical beta-blockers in patients with co-existing conditions: is this a cause for concern?
Good CB
Pharmacoepidemiol Drug Saf; 2001; 10(6):509-10. PubMed ID: 11828832
[No Abstract] [Full Text] [Related]
20. Bronchial and cardiovascular effects of ocular topical B-antagonists in asthmatic subjects: comparison of timolol, carteolol, and metipranolol.
Le Jeunne CL; Hugues FC; Dufier JL; Munera Y; Bringer L
J Clin Pharmacol; 1989 Feb; 29(2):97-101. PubMed ID: 2565918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
